FDA OKs outpatient trial for artificial pancreas

03/23/2012 | Medical News Today

The Artificial Pancreas Project, a collaboration among several universities, received FDA approval to conduct outpatient clinical trials in the U.S. for its hand-held device designed to automatically measure blood glucose levels and provide insulin as needed in type 1 diabetes patients. The trial could begin in about six weeks, one researcher said.

View Full Article in:

Medical News Today

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
European Sales Manager
SentreHEART, Inc.
Germany, Benelux, UK
REG AFFAIRS PROJ MGR - 1400000A7F
Abbott
San Jose, CA
SPECIALIST II SYSTEMS INTEGRATION - 140000033P
Abbott
Dallas, TX
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD